Enzyme Safely Starves Cancer Cells in Preclinical Study

thumbthomas breast cancer imagelg 0A research team led by scientists at The University of Texas Austin has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of Nature Medicine.

Dunn Receives TAMEST's 2017 O'Donnell Award in Engineering

Professor Andrew Dunn has developed technology that allows us to see things we haven't seen before in the human brain.

Engineers Develop First-Ever Capsule to Treat Hemophilia

In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.

Flu Vaccine’s Effectiveness Can Be Improved, New Findings Suggest

georgiou 74A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved. The findings were reported in the journal Nature Medicine on Nov. 7.

Research Leads to Better Understanding of Imprinting Proteins

HeidiCulverthumbIn a new paper in Biomacromolecules, researchers from Nicholas Peppas’ Laboratory of Biomaterials, Drug Delivery, and Bionanotechnology describe unexpected results in the field of protein imprinting.

Rice Takes 1st Place at MIT IEEE Undergraduate Research Technology Conference

Carlton Rice MITthumbUndergraduate student Carlton Rice won first place for his poster presentation in Biomedical Engineering at the 2016 MIT Institute of Electrical and Electronics Engineers (IEEE) Undergraduate Research Technology Conference.

Woojung Shin Receives IFER Graduate Student Fellowship

Woojung Shin thumbGraduate student Woojung Shin has received the IFER Graduate Student Fellowship in Alternatives in Scientific Research to research how microengineered human gut models inhabited by living gut bacteria can be used to replace animal colitis models.

New Clinical Partnership Uses Advanced Imaging Methods to Fight Breast Cancer

UT Austin has embarked on a two-year clinical study to test advanced imaging methods that could provide patients and physicians with new, valuable information on how to treat breast cancer in patients.

Peppas and Anslyn Receive NIH Funding to Improve Early Detection of Autoimmune Disorders

Professors Nicholas Peppas and Eric Anslyn have received a $1.3 million NIH grant to investigate using nanotechnology to noninvasively diagnose Sjögren’s syndrome.

Sacks Named Fellow of the American Heart Association

Sacks 2014thumbProfessor Michael Sacks has been named a Fellow of the American Heart Association (FAHA), a prestigious fellowship through the American Heart Association that recognizes “scientific and professional accomplishments and volunteer leadership and service.”

‘Connectosomes’ Create Gateway for Improved Chemo Delivery, Fewer Side Effects

Researchers have developed a new method that delivers chemotherapy directly and efficiently to individual cells.

Kwan Receives Kuhn Family IE Award

Ethan Kwan ThumbEthan Kwan, a biomedical engineering senior, has received the $1,000 Kuhn Family IE Award for Fall 2016.

Nicholas Peppas Receives 2016 Pritzker Distinguished Lectureship

Professor and world-renowned expert in biomaterials and drug delivery systems, has been awarded BMES' prestigious Robert A. Pritzker Distinguished Lecture Award for 2016.

Companies with Ties To BME Among Latest ATI Graduates

lightbulbTwo startups with connections to the Department of Biomedical Engineering have graduated from The University of Texas at Austin’s startup incubator, Austin Technology Incubator (ATI).

With Kenneth Rainin Foundation Innovator Award, Kim Takes Bioinspired Approach to Personalized Crohn’s Disease Treatment

Professor Hyun Jung Kim will use a gut-on-a-chip system to determine if fecal microbiota transplantation is an effective treatment for Crohn's disease.